Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mainz Biomed N.V. - Ordinary Shares
(NQ:
MYNZ
)
0.3031
+0.0051 (+1.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,002,009
Open
0.3000
Bid (Size)
0.2900 (3)
Ask (Size)
0.2987 (24)
Prev. Close
0.2980
Today's Range
0.2800 - 0.3150
52wk Range
0.1852 - 3.392
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 15, 2024
Via
Benzinga
Performance
YTD
-74.09%
-74.09%
1 Month
+24.73%
+24.73%
3 Month
-20.45%
-20.45%
6 Month
-65.18%
-65.18%
1 Year
-86.82%
-86.82%
More News
Read More
12 Health Care Stocks Moving In Monday's Intraday Session
October 14, 2024
Via
Benzinga
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
October 10, 2024
Via
Benzinga
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
October 08, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Via
Benzinga
Former Senior Advisor To Obama Joins Forces With Innovative Biotech To Catch Cancer Early
October 07, 2024
Via
News Direct
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
Via
Benzinga
Exposures
COVID-19
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
October 01, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
September 27, 2024
Via
Benzinga
Pfizer Advances On Its Cancer Journey
September 20, 2024
Via
Benzinga
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
September 18, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed (NASDAQ: MYNZ) And Liquid Biosciences Team Up To Fight Pancreatic Cancer With Early Detection Tool
September 05, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
September 04, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Early Cancer Detection Saves Lives - This Biotech Has A Promising New Test
September 03, 2024
Via
News Direct
Mainz Biomed Seeks FDA Approval For Colorectal Cancer Test It Says Is Nearly Twice As Sensitive As Others – A Look At Pipeline And Milestones
September 03, 2024
Via
News Direct
Exposures
Product Safety
Mainz Biomed's (NASDAQ: MYNZ) Cutting-Edge Colorectal Cancer Test Applies For FDA Breakthrough Status
July 31, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
July 30, 2024
Via
Benzinga
Exposures
COVID-19
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
July 25, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Pfizer And Mainz Provide Examples Of Using Emerging Technology For Good
July 10, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 09, 2024
Via
InvestorPlace
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
July 09, 2024
Via
Benzinga
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
July 09, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
Via
Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
July 02, 2024
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.